Type 2 diabetics with a prior heart attack who were given 40 infusions of EDTA chelation therapy compared to those given a placebo had a
according to a study called the Trial to Assess Chelation Therapy (TACT) that was sponsored by the National Center for Complementary and Integrative Health and the National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health which was the first large-scale, multicenter clinical trial on chelation therapy in people who have had heart attacks.
EDTA chelation only benefited diabetics
EDTA chelation only benefited diabetics; it did not benefit non-diabetics.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.